FogPharma is preclinical, but not for long. The biotech's Series D financing round lays the groundwork to bring its lead program into the clinic in mid-2023, as well as support development of the rest of its pipeline of peptide drugs.
At the 5th annual HLTH conference in Las Vegas, healthcare executives from companies such as Babson Diagnostics to Wheel responded to questions such as what's the difference between a positive and negative user experience in telehealth? They also previewed their plans for 2023.
INVEST 2023 will unite innovative startups, active investors as well as forward-thinking healthcare providers, payers and life science companies. Join us for exclusive networking opportunities and engaging content that highlights the opportunities and challenges the industry faces as it continues to evolve.
By Marissa Plescia Sunday, November 27, 2022 9:30 AM
Caregiver services and benefits specific to LGBTQ+ populations are some ways employers can support their employees. Executives shared these ideas on a panel at the HLTH conference in Las Vegas.
To help address the diabetes epidemic, providers should incorporate remote patient monitoring into the standard of care, according to Kaiser Permanente physician Dr. Sos Mboijana. When treating chronic conditions like diabetes, having access to a continuous flow of patient data is critical, he said.
By Girisha Fernando Sunday, November 27, 2022 9:00 AM
By leveraging its large membership, Medicare could by embracing value-based contracting significantly influence the pharmaceutical market, pitting competing drugs against each other, or encouraging pharmaceutical makers to figure out ways to deliver drugs more cheaply.
Among the takeaways from HLTH 2022 were the impact of consolidation on clinicians, behavioral health tools to help consumers manage stress and anxiety more productively, and how health tech and medtech companies are supporting remote patient monitoring and testing.
MedCity News 611 Broadway New York, NY 10012 United States
You received this email because you are subscribed to MedCity Daily Digest from MedCity News.
Update your email preferences to choose the types of emails you receive.
No comments